Takeda appoints rhonda pacheco president of the u.s. business unit

Cambridge, mass.--(business wire)--takeda (tse:4502/nyse:tak) today announced that rhonda pacheco, most recently group vice president of u.s. cardiometabolic health at eli lilly, will join takeda, effective september 29, as president of takeda's u.s. business unit and will be a member of the takeda executive team. pacheco will succeed julie kim, who was appointed by the takeda board of directors to succeed christophe weber as president and chief executive officer (ceo) of takeda in june 2026. w.
TAK Ratings Summary
TAK Quant Ranking